IP Library › Assignment 040264/0102
Patent Assignment
Reel/Frame 040264/0102

General Conveyance and Assumption Agreement

Recorded: 2016-10-24 Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property (1)
Novel Heterocyclic Compounds as Bromodomain Inhibitors
Patent: 9,598,367 →
Application: 14/997,213 →
Publication: US 2016/0130228
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 24, 2016
From: LIU, SHUANG; DUFFY, BRYAN CORDELL; JIANG, MAY XIAOWU; WANG, RUIFANG
To: RESVERLOGIX CORP.
Reel/Frame 040105/0799 →
Assignment of Assignor's Interest Oct 24, 2016
From: RESVERLOGIX CORP.
To: RVX THERAPEUTICS INC.
Reel/Frame 040105/0813 →
Change of Name Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →